That would cap the company at $300,000,000? For this to happen, the company would need to generate an EBIT of about $15m over the next fiscal period (07/08)? Could happen but I am more inclined to think that SBN may build its sales platform steadily as opposed to rapidly particularly given the current constraints of its sales force and the size of the market that they will be targeting. That is not to say of course that the sales team will not indirectly grow as major distributors come on board. Personally, I would like to see SBN evolve organically and the SP grow proportionately to this growth. As a general rule, I have tended to find that things that go up fast seem to have a propensity to fall back to earth just as quick, particularly in the absence of fundamentals. I think the prospects of some interesting news out of Mexico and Russia are possible providing the company's agents in those provinces get their respective acts together. Additionally, a stream of FDA news as indicated by the comapny is expected in Q1 2008 which will pave the way for further developments in China, the biggest market for the product in the world. My personal take barring any negative left field events is for a very positive news flow in Q1 2008.
Happy Xmas to all.
ciao
SBN Price at posting:
0.0¢ Sentiment: ST Buy Disclosure: Held
